Impact Biomedical Inc.
IBO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001834105
In the last 90 days, Impact Biomedical Inc. insiders filed 0 open-market purchases and 1 sale; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.76M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Impact Biomedical Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q1 2026
- Shares held
- 3.83M
- +112.0K (+3.0%) vs. Q1 2026
- Total value
- $1.76M
- −$469.5K (−21.0%) vs. Q1 2026
- New holders
- 3
- 4 more added
- Sold out
- 0
- 5 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.76M |
| Q1 2026 | 21 | $2.23M |
| Q4 2025 | 24 | $726.3K |
| Q3 2025 | 21 | $357.8K |
| Q2 2025 | 20 | $328.2K |
| Q1 2025 | 17 | $335.4K |
| Q4 2024 | 11 | $76.1K |
| Q3 2024 | 10 | $59.3K |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Impact Biomedical Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $0 | 0.00% | −352−99.7% | Reduced |
| Royal Bank of Canada | 32 | $0 | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 1 | $0 | 0.00% | +1 | New |
| Danske Bank A/S | 3 | $1 | 0.00% | 00.0% | Unchanged |
| Center for Financial Planning, Inc. | 0 | $1 | 0.00% | 0 | Unchanged |
| Burk Holdings LLC | 27 | $12 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 86 | $40 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 224 | $103 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 292 | $134 | 0.00% | +2+0.7% | Added |
| Global Trust Asset Management, LLC | 1,818 | $836 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,400 | $1.10K | 0.00% | −30,017−92.6% | Reduced |
| Morgan Stanley | 9,285 | $4.27K | 0.00% | +11+0.1% | Added |
| Mason & Associates Inc | 10,000 | $4.60K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 17,191 | $7.91K | 0.00% | −20,236−54.1% | Reduced |
| Jane Street Group, LLC | 24,528 | $11.3K | 0.00% | +24,528 | New |
| Vanguard Global Advisers, LLC | 32,201 | $14.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 49,567 | $22.8K | 0.00% | +49,567 | New |
| Northern Trust Corp | 235,475 | $108.3K | 0.00% | −8,468−3.5% | Reduced |
| BlackRock, Inc. | 259,946 | $119.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 589,428 | $271.1K | 0.00% | +4,230+0.7% | Added |
| State Street Corp | 607,897 | $279.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 808,689 | $372.0K | 0.00% | +100,521+14.2% | Added |
| Geode Capital Management, LLC | 1,185,163 | $545.6K | 0.00% | −7,762−0.7% | Reduced |
| CWM, LLC | – | – | – | – | Not filed |